​Cannabidiol (CBD) is a non-intoxicating compound found in the Cannabis sativa plant. Its effects on the human body are primarily mediated through the Endocannabinoid System (ECS), a complex cell-signaling system identified in the early 1990s by researchers investigating THC.

The Endocannabinoid System (ECS)

The ECS plays a crucial role in regulating a range of functions and processes, including sleep, mood, appetite, memory, and reproduction. It consists of three main components:

1. Endocannabinoids

These are cannabis-like molecules naturally produced by the body. They are signaling molecules that help keep internal functions running smoothly.

Endocannabinoid	Function
Anandamide (AEA)	Associated with the feeling of "bliss" and pain regulation.
2-Arachidonoylglycerol (2-AG)	Helps regulate mood, appetite, and immune system function.

2. Cannabinoid Receptors

Found throughout the body, these receptors are what endocannabinoids (and phytocannabinoids like CBD) bind to in order to signal the ECS to take action.

Receptor	Primary Location	Known Involvement
CB1 Receptors	Central Nervous System (Brain and spinal cord)	Coordination, movement, pain, cognition, appetite
CB2 Receptors	Peripheral Nervous System (Especially immune cells)	Pain, inflammation, immune response

3. Enzymes

These are responsible for breaking down endocannabinoids once they have carried out their function.

• Fatty acid amide hydrolase (FAAH): Breaks down Anandamide (AEA).
• Monoacylglycerol lipase (MAGL): Breaks down 2-Arachidonoylglycerol (2-AG).

How CBD Interacts with the ECS

Unlike Tetrahydrocannabinol (THC), which binds directly to CB1 receptors to produce a psychoactive "high," CBD has a more subtle, indirect interaction with the ECS.

1. Indirect Action on Receptors: CBD does not strongly bind to CB1 or CB2 receptors. Instead, it is thought to influence them indirectly.
2. Inhibition of Enzymes: CBD may inhibit the activity of the FAAH enzyme. By inhibiting FAAH, CBD can slow the breakdown of Anandamide (AEA), potentially allowing the naturally occurring endocannabinoid to remain in the system longer and exert a more sustained effect.
3. Interaction with Non-Cannabinoid Receptors: CBD also interacts with other receptors outside the ECS, such as:
   • Serotonin Receptors (5-HT1A): Associated with anti-anxiety and antidepressant effects.
   • Vanilloid Receptors (TRPV1): Associated with pain and inflammation.

Administration and Bioavailability

The way CBD is consumed affects how quickly it enters the bloodstream and how much of it the body can actually use (bioavailability).

Method of Administration	Description	Bioavailability	Onset Time
Inhalation (Vaping)	CBD is absorbed through the lungs.	High	Fast (Minutes)
Sublingual (Tinctures)	Held under the tongue for absorption into the bloodstream via mucous membranes.	Moderate to High	Medium (15-30 minutes)
Oral (Edibles, Capsules)	Must pass through the digestive system and liver (first-pass metabolism).	Low	Slow (30-90+ minutes)
Topical (Creams, Balms)	Applied directly to the skin; interacts with local ECS receptors.	Low (Localized effect)	Variable